American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic ...
American Shared Hospital Services (AMS) is a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services. The company's primary business model revolves around leasing sophisticated medical equipment to healthcare providers, thereby reducing the capital burden on hospitals while enabling them to offer cutting-edge treatments. Key products include Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat brain tumors, arteriovenous malformations, and trigeminal neuralgia, and proton beam radiation therapy systems, with centers operating in Orlando, Florida, and Long Beach, California. AMS also provides comprehensive support services including planning, installation, reimbursement guidance, and marketing strategies. As of December 31, 2021, the company's portfolio included 115 active Gamma Knife units in the U.S. and two in South America, along with one proton beam system. Financially, AMS has a market cap around $10.2 million and trades on NYSE Arca. While the company has faced recent negative profitability metrics (TTM net margin -5.3%), it maintains a gross profit margin of 18.5% and has a moderate debt-to-equity ratio of 0.9. Leadership includes CEO Craig K. Tagawa and Executive Chairman Raymond C. Stachowiak, a founder of Shared Imaging. With a lean workforce of 44 employees, the company continues to focus on expanding its technology offerings and supporting cancer centers through creative financial solutions and operational expertise. Future prospects depend on hospital capital budgets, adoption of advanced radiation therapies, and competition in the medical equipment leasing space.
